Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGASUS: Post-surgical Liquid Biopsy-guided Treatment of Colon Cancer
NCT04259944Phase 2Unknown
- Sponsor
- IFOM
- Start
- Jun 2020
- Primary completion
- Jul 2024
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Capecitabine + oxaliplatin, capecitabine, FOLFIRI in colon cancer, sponsored by IFOM. Status: unknown.
02
Drugs
Capecitabine + oxaliplatincapecitabineFOLFIRI
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT04259944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04259944.